A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
The main objective of this study is to assess the biological activity of CP-4126 in patients with advanced pancreatic cancer. In addition, the correlation between hENT1 (human equilibrative nucleoside transporter 1) and overall survival will be studied.
Advanced Adenocarcinoma of Pancreas
DRUG: IV CP-4126
Biological activity of CP-4126 in patients with advanced pancreatic cancer., Every second cycle
Overall survival, Objective response rate., Every second cycle - study length
The main objective of this study is to assess the biological activity of CP-4126 in patients with advanced pancreatic cancer. In addition, the correlation between hENT1 (human equilibrative nucleoside transporter 1) and overall survival will be studied.